SCHEMBL23090396

SCHEMBL23090396

CCn1ccc(NC(=O)c2cc3c(cc2OC)CCCCC3)n1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.53
▸ RAB9A P51151 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MAP3K5 Q99683 7/20 0.45
▸ PDGFRB P09619 1/20 0.43
▸ FLT4 P35916 1/20 0.43
▸ FLT3 P36888 1/20 0.43
▸ EPHX2 P34913 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ RAF1 P04049 1/20 0.40
▸ CACNA1G O43497 1/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ CACNA1I Q9P0X4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090414 0.80 DHODH (0.50) DHODHRAB9ANPC1MEN1LMNA
SCHEMBL23090376 0.74 DHODH (0.55) DHODHRAB9AMEN1LMNAKMT2A
SCHEMBL23090412 0.72 DHODH (0.71) DHODHRAB9ANPC1GAAMEN1
SCHEMBL23090386 0.71 ABCB1 (0.61) DHODHRAB9ANPC1GAAMEN1
SCHEMBL23090375 0.70 DHODH (0.59) DHODHRAB9ANPC1MEN1LMNA
SCHEMBL21468483 0.70 LMNA (0.52) DHODHRAB9AGAAMEN1LMNA
SCHEMBL23090371 0.69 DHODH (0.71) DHODHRAB9ANPC1MEN1LMNA
SCHEMBL23090382 0.69 DHODH (1.00) DHODHRAB9ANPC1MEN1LMNA
SCHEMBL23090368 0.67 DHODH (0.53) DHODHRAB9AMEN1LMNAKMT2A
SCHEMBL23090366 0.67 DHODH (0.57) DHODHRAB9ANPC1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885RAB9A 1095/4885NPC1 1391/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885RAB9A 1095/4885NPC1 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback